Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

34.15
+0.24570.72%
Post-market: 33.90-0.2457-0.72%16:10 EDT
Volume:89
Turnover:3K
Market Cap:2.56M
PE:- -
High:34.15
Open:33.90
Low:34.15
Close:33.90
52wk High:36.54
52wk Low:23.88
Shares:75.00K
Float Shares:75.00K
Volume Ratio:0.10
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

Guardant Health Price Target Announced at $203.00/Share by Rothschild & Co

Dow Jones
·
Sep 08

【US Pre-Market】Middle East Energy Risks Escalate, Brent Crude Nears $100, Oil and Gas Stocks Rise; Novartis Plunges 13%

TradingKey
·
Sep 08

Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 08

Press Release: Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Dow Jones
·
Sep 08

Alnylam price target raised to $260 from $230 at Jefferies

TIPRANKS
·
Sep 08

Guardant Health's Breast Cancer Diagnostic Approved by US FDA

MT Newswires Live
·
Sep 08

Rothschild & Co Redburn Initiates Guardant Health at Buy

MT Newswires Live
·
Sep 08

Everpure, Illumina Gain on S&P 500 Inclusion

Reuters
·
Sep 08

Guardant Health initiated with a Buy at Rothschild & Co Redburn

TIPRANKS
·
Sep 08

Insiders Shake Up Innovative, Alcoa, Illumina, Southern, Marathon

TIPRANKS
·
Sep 05

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05

S&P 500 Quarterly Shake-Up: AI Demand Propels Bloom Energy Into the Index, Alongside Illumina and Everpure

Stock News
·
Sep 05

Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P Smallcap 600

THOMSON REUTERS
·
Sep 05

Illumina Director Keith Meister Disposes of USD 30.51 Million in Common Shares

Reuters
·
Sep 05

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
Sep 05

Guardant Health Announces Landmark FDA Approval of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Breast Cancer

THOMSON REUTERS
·
Sep 05

S&P Dow Jones Indices: Bloom Energy, Illumina, and Everpure Set to Join S&P 500

THOMSON REUTERS
·
Sep 05

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

MT Newswires Live
·
Sep 04

Steris PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 04